Nationwide Nasal Spray Product Recall Expanded

People with weakened immune systems who use the recalled products may suffer life-threatening infections.

A nasal spray is given to a child, in this undated file photograph. Sung Pi-Lung/The Epoch Times

MediNatura New Mexico Inc. is expanding its recall of nasal spray products, citing microbial contamination, the company said in a Dec. 16 statement published by the Food and Drug Administration.

MediNatura announced on Dec. 10 the recall of one lot of ReBoost Nasal Spray, used to relieve conditions such as a runny nose, nasal congestion, sinus headache, nasal itching, and sneezing. In its latest announcement, the company expanded the recall to all lots of the product.

“The product has been found to contain yeast/mold and microbial contamination with one species identified as Achromobacter, at levels above specifications,” the company said.

Achromobacter is a bacterium that is “intrinsically resistant to several antibiotics,” according to an October 2020 study published in the National Library of Medicine. This intrinsic resistance of the bacteria to various antibiotics means there are only a few treatment options.

The recalled ReBoost Nasal Spray is packaged in 20 milliliter bottles, placed in white and yellow cartons, with UPC# 787647 10186 3, and comes with expiration dates ranging from December 2022 to December 2025.

MediNatura is also recalling all lots of ClearLife Allergy Nasal Spray as it’s been found to contain microbial contamination that could be linked to Achromobacter, the company said.

ClearLife Allergy Nasal Spray is used to temporarily relieve conditions such as itchy throat and skin, allergy-related headache, watery eyes, nasal congestion, and allergic rhinitis. The item is sold in 20 milliliter bottles packaged in white and green cartons, carries UPC# 787647 10188 7, with expiration dates of December 2022 to December 2025.

The recalled items were distributed online by MediNatura as well as through retail outlets nationwide.

“All customers should immediately discontinue using the products under recall,” the company said. “There is a reasonable probability that adverse health consequences including life-threatening infections will occur with use of the product in the immuno-compromised population. To date, MediNatura has not received any reports of adverse events related to this recall.”

Customers with queries can get in touch with MediNatura by calling 800-621-7644.

An undated image of the recalled MediNatura ReBoost nasal spray container. Courtesy of the FDA

The Epoch Times reached out to MediNatura for comment but did not receive a response by publication time.

In October, Sen. Rick Scott (R-Fla.) published an investigative report detailing America’s “dangerous reliance” on generic drugs manufactured abroad, according to an Oct. 22 statement from Scott’s office.

“The U.S. manufactured 37 percent of its consumed pharmaceuticals in 2024, a stark decline from 2002 when that figure was at 83 percent,” his office said. “China accounts for 95 percent of U.S. imports of ibuprofen, 70 percent of U.S. imports of acetaminophen, and upwards of 45 percent of U.S. imports of penicillin.”